Page 19 - Read Online

Page 14 of 16 Yeger et al. J Cancer Metastasis Treat 2020;6:26 I http://dx.doi.org/10.20517/2394-4722.2020.61

to-mesenchymal transition with a novel therapeutic combination of acetazolamide (AZ) and sulforaphane (SFN). Target Oncol
2016;11:209-27.
45. Malavolta M, Bracci M, Santarelli L, Sayeed A, Pierpaoli E, et al. Inducers of Senescence, toxic compounds, and senolytics: the multiple
faces of Nrf2-activating phytochemicals in cancer adjuvant therapy. Mediators Inflamm 2018;2018:4159013.
46. Li S, Chen M, Li Y, Tollefsbol TO. Prenatal epigenetics diets play protective roles against environmental pollution. Clin Epigenetics
2019;11:82.
47. Bell L, Oloyede OO, Lignou S, Wagstaff C, Methven L. Taste and flavor perceptions of glucosinolates, isothiocyanates, and related
compounds. Mol Nutr Food Res 2018;62:e1700990.
48. Wu QJ, Yang G, Zheng W, Li HL, Gao J, et al. Pre-diagnostic cruciferous vegetables intake and lung cancer survival among Chinese
women. Sci Rep 2015;5:10306.
49. Nigro C, Leone A, Fiory F, Prevenzano I, Nicolò A, et al. Dicarbonyl stress at the crossroads of healthy and unhealthy aging. Cells
2019;8:749.
50. Chikara S, Nagaprashantha LD, Singhal J, Horne D, Awasthi S, et al. Oxidative stress and dietary phytochemicals: role in cancer
chemoprevention and treatment. Cancer Lett 2018;413:122-34.
51. Lv HH, Zhen CX, Liu JY, Shang P. PEITC triggers multiple forms of cell death by GSH-iron-ROS regulation in K7M2 murine
osteosarcoma cells. Acta Pharmacol Sin 2020; doi: 10.1038/s41401-020-0376-8.
52. Liskova A, Kubatka P, Samec M, Zubor P, Mlyncek M, et al. Dietary phytochemicals targeting cancer stem cells. Molecules 2019;24:899.
53. Nguyen YT, Moon JY, Ediriweera MK, Cho SK. Phenethyl isothiocyanate suppresses stemness in the chemo- and radio-resistant triple-
negative breast cancer cell line MDA-MB-231/IR via downregulation of metadherin. Cancers (Basel) 2020;12:268.
54. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
55. Girotti MR, Salatino M, Dalotto-Moreno T, Rabinovich GA. Sweetening the hallmarks of cancer: Galectins as multifunctional mediators
of tumor progression. J Exp Med 2020;217:e20182041.
56. Tian H, Zhou Y, Yang G, Geng Y, Wu S, et al. Sulforaphane-cysteine suppresses invasion via downregulation of galectin-1 in human
prostate cancer DU145 and PC3 cells. Oncol Rep 2016;36:1361-8.
57. Abbaoui B, Lucas CR, Riedl KM, Clinton SK, Mortazavi A. Cruciferous vegetables, isothiocyanates, and bladder cancer prevention. Mol
Nutr Food Res 2018;62:e1800079.
58. Palliyaguru DL, Yuan JM, Kensler TW, Fahey JW. Isothiocyanates: translating the power of plants to people. Mol Nutr Food Res
2018;62:e1700965.
59. Mithen R, Ho E. Isothiocyanates for human health. Mol Nutr Food Res 2018;62:e1870079.
60. Baird L, Yamamoto M. The molecular mechanisms regulating the KEAP1-NRF2 pathway. Mol Cell Biol 2020;40:e00099-20.
61. Park JE, Sun Y, Lim SK, Tam JP, Dekker M, et al. Dietary phytochemical PEITC restricts tumor development via modulation of
epigenetic writers and erasers. Sci Rep 2017;7:40569.
62. Paul B, Li Y, Tollefsbol TO. The effects of combinatorial genistein and sulforaphane in breast tumor inhibition: role in epigenetic
regulation. Int J Mol Sci 2018;19:1754.
63. Hyun TK. A recent overview on sulforaphane as a dietary epigenetic modulator. Excli J 2020;19:131-4.
64. Martin SL, Royston KJ, Tollefsbol TO. The role of non-coding RNAs and isothiocyanates in cancer. Mol Nutr Food Res
2018;62:e1700913.
65. Lu Z, Zou J, Li S, Topper MJ, Tao Y, et al. Epigenetic therapy inhibits metastases by disrupting premetastatic niches. Nature
2020;579:284-90.
66. Mitsiogianni M, Amery T, Franco R, Zoumpourlis V, Pappa A, et al. From chemo-prevention to epigenetic regulation: the role of
isothiocyanates in skin cancer prevention. Pharmacol Ther 2018;190:187-201.
67. Sehrawat A, Roy R, Pore SK, Hahm ER, Samanta SK, et al. Mitochondrial dysfunction in cancer chemoprevention by phytochemicals
from dietary and medicinal plants. Semin Cancer Biol 2017;47:147-53.
68. Sarkar FH, Li YW. Targeting multiple signal pathways by chemopreventive agents for cancer prevention and therapy. Acta Pharmacol Sin
2007;28:1305-15.
69. Bijangi-Vishehsaraei K, Saadatzadeh MR, Wang H, Nguyen A, Kamocka MM, et al. Sulforaphane suppresses the growth of
glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways. J Neurosurg
2017;127:1219-30.
70. Lamy E, Scholtes C, Herz C, Mersch-Sundermann V. Pharmacokinetics and pharmacodynamics of isothiocyanates. Drug Metab Rev
2011;43:387-407.
71. Rakariyatham K, Wu X, Tang Z, Han Y, Wang Q, et al. Synergism between luteolin and sulforaphane in anti-inflammation. Food Funct
2018;9:5115-23.
72. Ibrahim A, Al-Hizab FA, Abushouk AI, Abdel-Daim MM. Nephroprotective effects of benzyl isothiocyanate and resveratrol against
cisplatin-induced oxidative stress and inflammation. Front Pharmacol 2018;9:1268.
73. Barrera LN, Cassidy A, Johnson IT, Bao Y, Belshaw NJ. Epigenetic and antioxidant effects of dietary isothiocyanates and selenium:
potential implications for cancer chemoprevention. Proc Nutr Soc 2012;71:237-45.
74. Paul B, Li Y, Tollefsbol TO. The effects of combinatorial genistein and sulforaphane in breast tumor inhibition: role in epigenetic
regulation. Int J Mol Sci 2018;19:1754.
75. Rakariyatham K, Yang X, Gao Z, Song M, Han Y, et al. Synergistic chemopreventive effect of allylisothiocyanate and sulforaphane on
non-small cell lung carcinoma cells. Food Funct 2019;10:893-902.